The therapeutic potential of apelin in kidney disease

FA Chapman, D Nyimanu, JJ Maguire… - Nature Reviews …, 2021 - nature.com
Chronic kidney disease (CKD) is a leading cause of global morbidity and mortality and is
independently associated with cardiovascular disease. The mainstay of treatment for CKD is …

Vascular effects of apelin: Mechanisms and therapeutic potential

A Mughal, ST O'Rourke - Pharmacology & therapeutics, 2018 - Elsevier
Apelin is a vasoactive peptide and is an endogenous ligand for APJ receptors, which are
widely expressed in blood vessels, heart, and cardiovascular regulatory regions of the brain …

Effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction

KF Docherty, RT Campbell, KJM Brooksbank… - Circulation, 2021 - Am Heart Assoc
Background: Patients with left ventricular (LV) systolic dysfunction after myocardial infarction
are at a high risk of developing heart failure. The addition of neprilysin inhibition to renin …

International union of basic and clinical pharmacology. CVII. Structure and pharmacology of the apelin receptor with a recommendation that elabela/toddler is a …

C Read, D Nyimanu, TL Williams, DJ Huggins… - Pharmacological …, 2019 - ASPET
The predicted protein encoded by the APJ gene discovered in 1993 was originally classified
as a class AG protein-coupled orphan receptor but was subsequently paired with a novel …

Apelin is a negative regulator of angiotensin II–mediated adverse myocardial remodeling and dysfunction

ZZ Zhang, W Wang, HY Jin, X Chen, YW Cheng… - …, 2017 - Am Heart Assoc
The apelin pathway has emerged as a critical regulator of cardiovascular homeostasis and
disease. However, the exact role of pyr1-apelin-13 in angiotensin (Ang) II–mediated heart …

[HTML][HTML] Apelinergic system structure and function

K Shin, C Kenward, JK Rainey - Comprehensive Physiology, 2017 - ncbi.nlm.nih.gov
Apelin and apela (ELABELA/ELA/Toddler) are two peptide ligands for a class A G-protein-
coupled receptor named the apelin receptor (AR/APJ/APLNR). Ligand-AR interactions have …

[HTML][HTML] Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases

JC Zhong, ZZ Zhang, W Wang, SMK McKinnie… - … et Biophysica Acta (BBA …, 2017 - Elsevier
The apelin/apelin receptor system is widely distributed and has a dominant role in
cardiovascular homeostasis and disease. The apelin gene is X-linked and is synthesized as …

Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists

AA de Oliveira, A Vergara, X Wang, JC Vederas… - Peptides, 2022 - Elsevier
The apelin/apelin receptor (ApelinR) signal transduction pathway exerts essential biological
roles, particularly in the cardiovascular system. Disturbances in the apelin/ApelinR axis are …

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling

NH Mustafa, J Jalil, S Zainalabidin… - Frontiers in …, 2022 - frontiersin.org
Cardiovascular diseases have become a major clinical burden globally. Heart failure is one
of the diseases that commonly emanates from progressive uncontrolled hypertension. This …

Apelin/APJ system: an emerging therapeutic target for neurological diseases

A Li, Q Zhao, L Chen, Z Li - Molecular Biology Reports, 2023 - Springer
Apelin, an endogenous ligand for the G protein-coupled receptor APJ, is extensively
expressed in various systems, especially the nervous system. This article reviews the role of …